PROMOMED Company took part in the Mother and Child Forum

26.09.2025

PROMOMED participated in the XXVI All-Russian Scientific and Educational Forum "Mother and Child", which brought together more than five thousand doctors and experts from all over the country.


One of the centers of attraction of the participants at the event was a stand dedicated to the return of josamycin to the domestic market as a drug "Vilpramycin SAR". The stand attracted a large number of gynecologists, specialists participated in interactive sessions, shared their experiences and discussed complex clinical cases.


A notable event in the business program of the forum was the PROMOMED Company symposium, chaired by Igor Baranov, MD, Professor, Head of the Department of Scientific and Educational Programs at the Kulakov National Research Medical Center, Vice President of the Russian Academy of Sciences. Presentations were made by the leaders of Russian gynecology: Inna Apolikhina, MD, Professor, Honored Physician of the Russian Federation, Head of the Department of Aesthetic Gynecology and Rehabilitation of the V.I. Kulakov National Research Medical Center; Inna Apolikhina, MD, Professor, Chairman of the Ethics (Bioethics) Committee of the Russian Academy of Sciences, President of the All-Russian Public Organization Russian Association for Genital Diseases infections and neoplasia", Honored Scientist of the Russian Federation Evgeny Kira.


The experts discussed modern approaches to antibacterial therapy, presented new data on josamycin, and shared clinical recommendations for practicing physicians.


The Mother and Child Forum has traditionally been an effective platform for the formation of new concepts and business relationships in the professional community. For PROMOMED, participation has become an important opportunity to show that domestic drugs can be effective, safe and convenient for both the doctor and the patient.

Get the most interesting news and publications first!

Sent successfully!

Pharmacovigilance

Press office

To request a press release or interview, please contact our press office